C92.90
Myeloid leukemia, unspecified, not having achieved remission
Clinical Classification Guidelines
Inclusion Terms
- Myeloid leukemia, unspecified with failed remission
- Myeloid leukemia, unspecified NOS
Medical Intelligence & Overview
Myeloid leukemia is a type of blood cancer that affects the bone marrow—the soft tissue inside bones where blood cells are produced. When diagnosed as 'unspecified' under ICD-10 code C92.90, it indicates a form of myeloid leukemia that hasn't been classified into a specific subtype. Additionally, the note about 'not having achieved remission' signals that the disease persists despite treatment efforts. This condition can be challenging to manage and requires ongoing medical attention.
Causes & Symptoms
Clinical Causes: Genetic mutations or abnormalities in the blood cell precursors Exposure to certain chemotherapy drugs or radiation therapy in the past Exposure to toxic chemicals, such as benzene Inherited genetic disorders, like Down syndrome History of blood disorders or previous cancers
Key Symptoms: Fatigue and weakness Unexplained weight loss Fever and frequent infections Easy bruising or bleeding Bone pain or tenderness Swelling of the spleen or liver Night sweats Shortness of breath
Diagnostic & Treatment
Diagnosis Path: Diagnosing this form of myeloid leukemia involves several steps. Blood tests, including a complete blood count (CBC), can reveal abnormal blood cell levels. Bone marrow biopsies help determine the presence of leukemia cells and confirm the subtype. Additional tests, such as genetic analyses and molecular studies, are used to understand the specific characteristics of the disease and to guide treatment planning. Since the condition is labeled 'unspecified,' detailed testing may be essential to rule out other types or subtypes.
Treatment Protocols: Treating myeloid leukemia typically involves chemotherapy to destroy cancerous cells. In cases where remission has not been achieved, more aggressive treatments, such as stem cell transplants, might be considered. Supportive care, like blood transfusions and antibiotics, may help manage symptoms and prevent infections. Clinical trials and targeted therapies are also options under evaluation for resistant cases. Ongoing medical supervision is essential to monitor disease progression and response to treatment.
Clinical Advice & FAQs
Billing Guidance
Is C92.90 a billable ICD-10 code?
Yes, C92.90 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C92.90?
Clinical documentation must specify the nature of Myeloid leukemia, unspecified, not having achieved remission and any associated comorbidities for accurate reporting.
Cite this Clinical Reference